Review Article
Volume 12 Issue 7 - 2020
The Control and Treatment of Neurological Complications in COVID-19 Pandemic Era
Hyunjo Kim1* and Jae-Hoon Song2
1School of Pharmacy, Yonsei University, South Korea
2Chairman of Asian-Pacific Research Foundation for Infectious and ANSORP, South Korea
*Corresponding Author: Hyunjo Kim, School of Pharmacy, Yonsei University, Incheon City, South Korea.
Received: May 20, 2020; Published: June 30, 2020




Abstract

The novel coronavirus (COVID-19) is a family of large enveloped non-segmented positive-sense RNA viruses which has been considered as a global health concern. COVID-19 itself has been a very high transmissibility potential, which declared as pandemic by WHO. It is postulated that the COVID-19 accumulates mainly in the nasal epithelia and lower respiratory airways. However, there is evidence suggesting the COVID-19 neurotropism which might contribute to respiratory failure. The magnitude of the COVID‐19 pandemic will result in substantial neurological disease, whether through direct infection, para‐infectious complications, or critical illness more generally. Thus, we aim to review the central nervous system complications of the COVID-19 and how to control and treat since the emergence of the virus in this study.

Keywords: Novel Coronavirus; COVID-19; CNS Complication; Neuropathy; Autoimmune System; CNS Disorder Treatment

References

  1. Chen N., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study”. Lancet 10223 (2020):507-513.
  2. Hui DS., et al. ‘The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China”. The International Journal of Infectious Diseases 91 (2020):264-266.
  3. Wu P., et al. “Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020”. Eurosurveillance 25 (2020).
  4. Wang W., et al. “Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China”. Journal of Medical Virology4 (2020): 441-447.
  5. Lu R., et al. “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding”. Lancet 395 .10224 (2020): 565-574.
  6. Paraskevis D., et al. “Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event”. Infection, Genetics and Evolution 79 (2020):104212.
  7. Assiri A., et al. “Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study”. The Lancet Infectious Diseases 213 (2013): 752-761.
  8. Wan Y., et al. “Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS”. Journal of Virology (2020).
  9. Liu Y., et al. “The reproductive number of COVID-19 is higher compared to SARS coronavirus”. Journal of Travel Medicine (2020).
  10. Ji W., et al. “Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human”. Journal of Medical Virology 4 (2020): 433-440.
  11. Chan JF., et al. “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster”. Lancet 10223 (2020): 514-523.
  12. De Wit E., et al. “SARS and MERS: recent insights into emerging coronaviruses”. Nature Reviews Microbiology 8 (2015): 523-534.
  13. Huang C, et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet (London, England) 395 (2020): 497-506.
  14. Wang D, et al. “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. The Journal of the American Medical Association (2019).
  15. Alenina N, Bader M. “ACE2 in brain physiology and pathophysiology: Evidence from transgenic animal models”. Neurochemical Research 44 (2019): 1323-1329.
  16. Burchill L, et al. “Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression”. Experimental Physiology 93 (2008): 622-630.
  17. Li YC., et al. “The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVCID-19 patients”. Journal of Medical Virology (2020).
  18. Román GC., et al. “On behalf of the World Federation of Neurology Environmental Neurology Specialty Group COVID-19 international neurological registries”. The Lancet Neurology (2020).
  19. Desforges M., et al. “Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?” Viruses 12 (2019).
  20. Li Y.C., et al. “Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells”. Virus Research 163 (2012): 628-635.
  21. Hatanpaa K., et al. “Neuropathology of viral infections”. Handbook of Clinical Neurology 123 (2014): 193-214.
  22. Kumar AM., et al. “Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction”. The Journal of Neuro Virology 13 (2007): 210-224.
  23. Nath A and Tyler KL. “Novel approaches and challenges to treatment of central nervous system viral infectios”. Annals of Neurology 74 (2013): 412-422.
  24. Campbell H., et al. “Review of the effect of measles vaccination on the epidemiology of SSPE”. International Journal of Epidemiology 36 (2007): 1334-1348.
  25. Lundberg P., et al. “The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis”. Journal of Virology 82 (2008): 7078-7088.
  26. Gorry PR., et al. “Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia”. Current HIV Research 1 (2013): 463-473.
  27. Hung EC., et al. “Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome”. Clinical Chemistry 49 (2003): 2108-2109.
  28. Moldofsky H and Patcai J. “Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome: a case-controlled study”. BMC Neurology 11 (2011): 37.
  29. Li Y., et al. “Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study”. Lancet (2020).
  30. Baig AM., et al. “Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host−virus interaction, and proposed neurotropic mechanisms”. ACS Chemical Neuroscience (2020).
  31. Stephanie A Bannister., et al. “Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species”. High-Throughput 4 (2018): 32.
  32. Schlaaff K., et al. “Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients”. Brain, Behavior, and Immunity 20 (2020): S0889-S1591.
  33. Maragkos GA., et al “Flow Diversion Endovascular Treatment Improves Headaches in Patients with Unruptured Intracranial Aneurysms”. World Neurosurgery S1878-8750 (2020): 30916-30915.
  34. Poyiadji N., et al “COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features”. Radiology 31 (2020): 201187.
  35. Netland J., et al. “Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2”. Journal of Virology 82 .15 (2008): 7264-7275.
  36. Li YC., et al. “The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients”. Journal of Medical Virology 10 (2020).
  37. Zhao H., et al. “Guillain-Barré syndrome associated with SARS-CoV-2 infection: Causality or coincidence?” Lancet (2020).
  38. Moriguchi T., et al. "A first case of meningitis/encephalitis associated with SARS-Coronavirus-2”. The International Journal of Infectious Diseases (2020).
  39. Filatov A., et al. “Neurological complications of coronavirus disease (COVID-19): encephalopathy”. Cureus 12 (2020).
  40. Calvet GA., et al. “First detection of autochthonous Zika virus transmission in a HIV-infected patient in Rio de Janeiro, Brazil”. Journal of Clinical Virology 74 (2016): 1-3.
  41. Baig AM., et al. “Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms”. ACS Chemical Neuroscience 7 (2020): 995-998.
  42. Chen C., et al. “Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies”. Zhonghua Shao Shang Za Zhi 36 (2020): E005.
  43. Fu Y., et al. “Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools”. Virologica Sinica (2020).
  44. Cristallo A., et al. “Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients”. Microbiologica 20 (1999):105-114.
  45. Bhatia R., et al. “Consensus statement - suggested recommendations for acute stroke management during the COVID-19 pandemic: expert group on behalf of the Indian Stroke Association”. Annals of Indian Academy of Neurology 23 (2020): 5-14.
  46. Boucher A., et al. “Long-term human coronavirus- myelin cross-reactive T-cell clones derived from multiple sclerosis patients”. Journal of Clinical Immunology 3 (2007): 258-267.
  47. Jin H., et al. “Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists”. Stroke and Vascular Neurology (2020).
  48. Steardo L., et al. “Neuroinfection may contribute to pathophysiology and clinical manifestation of COVID-19”. Acta Physiologica (2020).
  49. Li Q., et al. “Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia”. The New England Journal of Medicine (2020).
  50. Nishiura H., et al. “The extent of transmission of novel coronavirus in Wuhan, China”. Journal of Clinical Medicine 2 (2020): 330.
Citation: Hyunjo Kim and Jae-Hoon Song. The Control and Treatment of Neurological Complications in COVID-19 Pandemic Era”. EC Neurology 12.7 (2020): 97-108.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for September Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the September issue of respective journals. Submissions are accepted on/before August 21, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk